Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Clinical trial NCT06221774 · UNKNOWN

Trial details

NCT number: NCT06221774
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Carcinoma Urothelial Carcinoma Metastatic Castration-resistant Prostate Cancer

Start date: 2024-02-01
Primary completion: 2025-08-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.